Green Cross Lab Cell Corporation (144510) - Total Liabilities
Based on the latest financial reports, Green Cross Lab Cell Corporation (144510) has total liabilities worth ₩134.23 Billion KRW (≈ $90.97 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Green Cross Lab Cell Corporation - Total Liabilities Trend (2015–2024)
This chart illustrates how Green Cross Lab Cell Corporation's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Green Cross Lab Cell Corporation to evaluate short-term liquidity relative to the company's equity base.
Green Cross Lab Cell Corporation Competitors by Total Liabilities
The table below lists competitors of Green Cross Lab Cell Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lotte Chemical Titan Holding BHD
KLSE:5284
|
Malaysia | RM12.88 Billion |
|
Fks Multi Agro Tbk
JK:FISH
|
Indonesia | Rp295.89 Million |
|
Talisker Resources Ltd
TO:TSK
|
Canada | CA$54.58 Million |
|
Berjaya Assets Bhd
KLSE:3239
|
Malaysia | RM1.19 Billion |
|
ChargePoint Holdings Inc
NYSE:CHPT
|
USA | $730.09 Million |
|
Lanson BCC SA
PA:ALLAN
|
France | €725.61 Million |
|
Eaton Vance New York MBF
NYSE MKT:ENX
|
USA | $86.56 Million |
|
Nkarta Inc
NASDAQ:NKTX
|
USA | $86.21 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Green Cross Lab Cell Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Green Cross Lab Cell Corporation market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.60 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Green Cross Lab Cell Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Green Cross Lab Cell Corporation (2015–2024)
The table below shows the annual total liabilities of Green Cross Lab Cell Corporation from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩120.56 Billion ≈ $81.70 Million |
-2.53% |
| 2023-12-31 | ₩123.69 Billion ≈ $83.82 Million |
-10.42% |
| 2022-12-31 | ₩138.07 Billion ≈ $93.57 Million |
+2.60% |
| 2021-12-31 | ₩134.57 Billion ≈ $91.20 Million |
+360.97% |
| 2020-12-31 | ₩29.19 Billion ≈ $19.78 Million |
+21.56% |
| 2019-12-31 | ₩24.02 Billion ≈ $16.27 Million |
+151.56% |
| 2018-12-31 | ₩9.55 Billion ≈ $6.47 Million |
+35.76% |
| 2017-12-31 | ₩7.03 Billion ≈ $4.77 Million |
+9.59% |
| 2016-12-31 | ₩6.42 Billion ≈ $4.35 Million |
-18.81% |
| 2015-12-31 | ₩7.90 Billion ≈ $5.36 Million |
-- |
About Green Cross Lab Cell Corporation
GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC. GC Cell Corporation has strategic agreement with Lukas Biomedical Co., Ltd. to develop Cell therapy. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in Nove… Read more